Status:
COMPLETED
NovellusDx Cancer Early Detection Blood Test- Clinical Trial
Lead Sponsor:
Fore Biotherapeutics
Conditions:
Lung Cancer
Eligibility:
All Genders
18+ years
Brief Summary
NovellusDx early detection test is a simple to perform blood test, which identifies the deregulated signaling pathways within the patient tumor based on protein secretion to the blood, thus enabling e...
Eligibility Criteria
Inclusion
- subjects ages 18 and above ICF obtain
Exclusion
- none
Key Trial Info
Start Date :
June 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01883388
Start Date
June 1 2013
Last Update
March 29 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rambam MC
Haifa, Israel, 31096